Neuropathology of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuroimaging clinics of North America

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.NIC.2005.09.003PMID 16443488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.

  2005cited by this paper
• Senile plaque-like structures: observation of a probably unknown type of senile plaque by periodic-acid methenamine silver (PAM) electron microscopy

  2004cited by this paper
• Vascular Smooth Muscle Actin Is Reduced in Alzheimer Disease Brain: A Quantitative Analysis

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein

  2004cited by this paper
• Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques

  2004cited by this paper
• Neurodegeneration : the molecular pathology of dementia and movement disorders

  2003cited by this paper
• Greenfield's Neuropathology

  2002cited by this paper
• Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.

  1999cited by this paper
• Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease

  1998cited by this paper
• Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.

  1998cited by this paper
• Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

  1998cited by this paper
• Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.

  1998cited by this paper
• Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus.

  1997cited by this paper
• Staging of Alzheimer-type pathology: an interrater-intrarater study.

  1997cited by this paper
• Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts.

  1997cited by this paper
• Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Neocortical neuron number in humans: Effect of sex and age

  1997cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• Neurofibrillary tangles, but not Alzheimer‐type pathology, in a young boxer

  1996cited by this paper
• Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

  1995cited by this paper
• Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension.

  1995cited by this paper
• Atomic force microscopy of paired helical filaments isolated from the autopsied brains of patients with Alzheimer's disease and immunolabeled against microtubule-associated protein tau.

  1995cited by this paper
• The Olfactory Bulb in Alzheimer Disease: A Morphologic Study of Neuron Loss, Tangles, and Senile Plaques in Relation to Olfaction

  1994cited by this paper
• Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1994cited by this paper
• Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.

  1994cited by this paper
• Hirano bodies accumulate C-terminal sequences of beta-amyloid precursor protein (beta-APP) epitopes.

  1993cited by this paper
• Regionally specific loss of neurons in the aging human hippocampus.

  1993cited by this paper
• Computer‐Assisted Three‐Dimensional Image Analysis of Cerebral Amyloid Angiopathy

  1993cited by this paper
• Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older.

  1993cited by this paper
• Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists.

  1993cited by this paper
• Synaptic Pathology of Alzheimer's Disease a

  1993cited by this paper
• Hirano Bodies Accumulate C-Terminal Sequences of ß-Amyloid Precursor Protein (ß-APP) Epitopes

  1993cited by this paper
• Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

  1992cited by this paper
• Cell loss in the nucleus raphes dorsalis in Alzheimer's disease.

  1992cited by this paper
• Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Identification of normal and pathological aging in prospectively studied nondemented elderly humans.

  1992cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Protein kinase C alteration is an early biochemical marker in Alzheimer's disease

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.

  1991cited by this paper
• Induction of basic fibroblast growth factor in Alzheimer's disease pathology.

  1990cited by this paper
• General and dramatic glial reaction in Alzheimer brains

  1990cited by this paper
• Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

  1990cited by this paper
• Estimated prevalence of Alzheimer's disease in the United States.

  1990cited by this paper
• Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer's disease hippocampus.

  1989cited by this paper
• Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

  1989cited by this paper
• Neuropathological diagnosis of Alzheimer disease.

  1989cited by this paper
• Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain.

  1989cited by this paper
• Diffuse type of senile plaques in the brains of Alzheimer-type dementia

  1988cited by this paper
• Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

  1988cited by this paper
• Clinico‐pathologic studies in dementia

  1988cited by this paper
• Complement activation in amyloid plaques in Alzheimer’s dementia

  1988cited by this paper
• Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases

  1988cited by this paper
• The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.

  1988cited by this paper
• Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease.

  1988cited by this paper
• The prevalence of dementia: A quantitative integration of the literature

  1987cited by this paper
• Neocortical cell counts in normal human adult aging

  1987cited by this paper
• Hirano Body Filaments Contain Actin and Actin‐Associated Proteins

  1987cited by this paper
• Hirano bodies contain tau protein.

  1987cited by this paper
• Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications

  1986cited by this paper
• Sequestration of tubulin in neurons in Alzheimer's disease.

  1986cited by this paper
• Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments.

  1985cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper
• Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

  1983cited by this paper
• Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage.

  1983cited by this paper
• Phosphorylation of microtubule-associated proteins regulates their interaction with actin filaments.

  1983cited by this paper
• The Association of Actin with Hirano Bodies

  1983cited by this paper
• Plaques, tangles and dementia. A quantitative study.

  1982cited by this paper
• Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration.

  1981cited by this paper
• Fibrous Astrocytes in Senile Dementia of the Alzheimer Type

  1981cited by this paper
• Amygdaloid changes in aging and dementia.

  1980cited by this paper
• Clinicopathologic studies of primary cerebral amyloid angiopathy.

  1979cited by this paper
• Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia

  1979cited by this paper
• Numbers of Hirano bodies in the hippocampus of normal and demented people with Alzheimer's disease.

  1977cited by this paper
• Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

  1977cited by this paper
• GRANULOVACUOLAR DEGENERATION IN THE AGEING BRAIN AND IN DEMENTIA

  1977cited by this paper
• Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies.

  1966cited by this paper
• ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY.

  1964cited by this paper
• ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA.

  1964cited by this paper
• Uber eine eigenartige Erkrankung der Hirnrinde

  year unknowncited by this paper

• Upregulation of NLRP3 Inflammasome in Specific Hippocampal Regions: Strengthening the Link Between Neuroinflammation and Selective Vulnerability in Alzheimer’s Disease

  2025cites this paper
• The correlation between neuropathology levels and cognitive performance in centenarians

  2023cites this paper
• Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future

  2023cites this paper
• Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice

  2023cites this paper
• Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data

  2022cites this paper
• Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age‐continuous perspective

  2022cites this paper
• The complexity of Alzheimer's disease: an evolving puzzle.

  2021cites this paper
• Guggulu [Commiphora wightii (Arn.) Bhandari.]

  2021cites this paper
• Microdissected Pyramidal Cell Proteomics of Alzheimer Brain Reveals Alterations in Creatine Kinase B-Type, 14-3-3-γ, and Heat Shock Cognate 71

  2021cites this paper
• Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation.

  2021cites this paper
• Co-Prevalence of Alzheimer’s Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis

  2020cites this paper
• Aβ Plaques.

  2020cites this paper
• Age-Specific Retinal and Cerebral Immunodetection of Amyloid-β Plaques and Oligomers in a Rodent Model of Alzheimer’s Disease

  2020cites this paper
• Nootropic medicinal plants: Therapeutic alternatives for Alzheimer’s disease

  2019cites this paper
• Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer’s and Lewy Body Diseases

  2019cites this paper
• Comorbidity of age-related macular degeneration with Alzheimer’s disease: A histopathologic case-control study

  2019cites this paper
• Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study

  2018cites this paper
• Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates

  2018cites this paper
• Exercise Improves Recognition Memory and Acetylcholinesterase Activity in the Beta Amyloid-Induced Rat Model of Alzheimer’s Disease

  2018cites this paper
• Exploring novel autoantibodies within Alzheimer ' s disease

  2018influential citation
• Sleep and Alzheimer's disease: A pivotal role for the suprachiasmatic nucleus.

  2017cites this paper
• Hematopoietic Gene Therapies for Metabolic and Neurologic Diseases.

  2017cites this paper
• Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer’s disease

  2016cites this paper
• Multimodality Review of Amyloid-related Diseases of the Central Nervous System.

  2016cites this paper
• Salvia miltiorrhiza: A source for anti-Alzheimer’s disease drugs

  2016cites this paper
• [Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia].

  2015cites this paper
• HemeOxygenase-1: Transducer of Sterol Dys-Regulation in Alzheimer

  2014cites this paper
• The role of microglia in human disease: therapeutic tool or target?

  2014cites this paper
• Klinisch-validierte molekulare Biomarker neurodegenerativer Demenzerkrankungen

  2014cites this paper
• Klinisch-validierte molekulare Biomarker neurodegenerativer Demenzerkrankungen

  2014cites this paper
• Neuroimaging and the search for a cure for Alzheimer disease.

  2013cites this paper
• Coffee and Alzheimer's Disease: Animal and Cellular Evidence

  2012cites this paper
• Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

  2012cites this paper
• Model Hirano Bodies Protect against Tau-Independent and Tau-Dependent Cell Death Initiated by the Amyloid Precursor Protein Intracellular Domain

  2012cites this paper
• Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease

  2012cites this paper
• Does Apolipoprotein E modify the association of cerebral infarcts with Alzheimer's disease?

  2011influential citation
• Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery

  2011cites this paper
• Multiphoton in vivo imaging of amyloid in animal models of Alzheimer's disease.

  2010cites this paper
• Valproic acid as a promising agent to combat Alzheimer's disease.

  2010cites this paper
• Modulation of Amyloid β Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate

  2010cites this paper
• Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.

  2010cites this paper
• Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.

  2010cites this paper
• Cardiovascular Dementia - A Different Perspective

  2010cites this paper
• Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.

  2010cites this paper
• Modulation of amyloid beta peptide(1-42) cytotoxicity and aggregation in vitro by glucose and chondroitin sulfate.

  2010cites this paper
• Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review

  2009influential citation
• Neurodegenerative diseases.

  2008cites this paper
• Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

  2008cites this paper
• The localization of c-Abl in Alzheimer's disease

  2008cites this paper
• Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

  2008cites this paper
• Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.

  2008cites this paper
• Immunophenotypes in the circulation of patients with mild cognitive impairment.

  2008cites this paper
• Development of photocrosslinked sialic acid containing polymers for use in Abeta toxicity attenuation.

  2008cites this paper
• Neuropathology for the Neuroradiologist: Plaques and Tangles

  2008cites this paper
• AICD and its Adaptors – In Search of New Players

  2007cites this paper
• Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.

  2007cites this paper
• 100 years of Alzheimer’s disease research: are we any closer to a cure?

  2007influential citation
• Various Dendritic Abnormalities Are Associated with Fibrillar Amyloid Deposits in Alzheimer's Disease

  2007cites this paper
• Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells

  2007cites this paper
• The coming problem of HIV-associated Alzheimer's disease.

  2007cites this paper
• Natural antioxidants in Alzheimer's disease

  2007cites this paper
• PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis.

  2007cites this paper
• Tau is actin up in Alzheimer's disease

  2007cites this paper
• ABCB1 (P-glycoprotein) and blood-brain barrier: role in neurological diseases and their treatments

  2006cites this paper
• The M694V Variant of the Familial Mediterranean Fever Gene Is Associated with Sporadic Early-Onset Alzheimer’s Disease in an Italian Population Sample

  2006cites this paper
• Alzheimer's disease--an interactive perspective.

  2006influential citation
• Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease

  2006cites this paper
• Imaging Alzheimer's disease pathology: one target, many ligands.

  2006cites this paper
• ABCB1 (P-glycoprotéine) et barrière hémato-encéphalique : implication dans les maladies neurologiques et leurs traitements

  2006cites this paper